The study encompassed information from 21 clinics across four U.S
The US Food and Drug Administration recently approved a phase II clinical trial of afamelanotide (SCENESSE, Clinuvel Pharmacueticals Ltd) combined with narrowband UV-B therapy for the treatment of vitiligo.4 We report the case of a 25-year-old man who came to our department for the sudden eruption of multiple melanocytic nevi and rapid transformation of existing nevi
Personalized Care: Our program includes comprehensive consultations and health assessments by a licensed, board-certified physician assistant who will tailor your treatment plan to your needs
But, like, like, I cannot imagine going to my local CVS in my hometown and having to, like, go on the intercom
Remien CH, Adler FR, Waddoups L, Box TD, Sussman NL: Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death